Projected Income Statement: Albemarle Corporation

Forecast Balance Sheet: Albemarle Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 2,825 1,955 1,718 3,277 2,324 2,107 2,031 1,770
Change - -30.8% -12.12% 90.75% -29.08% -9.33% -3.61% -12.85%
Announcement Date 2/17/21 2/16/22 2/15/23 2/14/24 2/12/25 - - -
1USD in Million
Estimates

Cash Flow Forecast: Albemarle Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 850.5 953.7 1,262 2,149 1,686 600.1 671.4 723.1
Change - 12.13% 32.29% 70.36% -21.56% -64.4% 11.89% 7.69%
Free Cash Flow (FCF) 1 -51.56 -609.4 646.2 -824 -983.7 362.4 417.9 725
Change - -1,081.87% 206.04% -227.51% -19.39% 136.84% 15.31% 73.5%
Announcement Date 2/17/21 2/16/22 2/15/23 2/14/24 2/12/25 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Albemarle Corporation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 26.17% 26.17% 47.48% 35.05% 21.2% 21.09% 24.43% 28.8%
EBIT Margin (%) 18.75% 18.54% 43.37% 30.57% 10.25% 5.01% 13.74% 18.29%
EBT Margin (%) 11.94% 4.02% 33.24% 2.57% -32.8% -8.42% 1.74% 5.63%
Net margin (%) 12.01% 3.72% 36.75% 16.36% -24.47% -5.83% 4.44% 9.99%
FCF margin (%) -1.65% -18.31% 8.83% -8.57% -18.29% 7.21% 7.13% 11.52%
FCF / Net Income (%) -13.72% -492.76% 24.02% -52.37% 74.75% -123.52% 160.38% 115.41%

Profitability

        
ROA 3.7% 4.39% 19.57% 15.54% -1.58% -0.96% 1.47% 3.34%
ROE 9.16% 8.31% 19.01% 30.12% -2.84% -1.36% 2.88% 6.35%

Financial Health

        
Leverage (Debt/EBITDA) 3.45x 2.24x 0.49x 0.97x 2.04x 1.99x 1.42x 0.98x
Debt / Free cash flow -54.79x -3.21x 2.66x -3.98x -2.36x 5.82x 4.86x 2.44x

Capital Intensity

        
CAPEX / Current Assets (%) 27.18% 28.66% 17.24% 22.35% 31.35% 11.93% 11.45% 11.49%
CAPEX / EBITDA (%) 103.88% 109.49% 36.3% 63.77% 147.91% 56.57% 46.87% 39.9%
CAPEX / FCF (%) -1,649.39% -156.49% 195.24% -260.85% -171.37% 165.59% 160.67% 99.73%

Items per share

        
Cash flow per share 1 7.48 2.972 16.2 11.25 5.974 8.114 9.134 11.64
Change - -60.27% 445.01% -30.52% -46.91% 35.83% 12.56% 27.49%
Dividend per Share 1 1.54 1.56 1.58 1.6 1.61 1.626 1.651 1.65
Change - 1.3% 1.28% 1.27% 0.63% 1.02% 1.53% -0.06%
Book Value Per Share 1 39.95 48.07 67.77 80.17 84.74 84.44 84.04 85.57
Change - 20.34% 40.97% 18.3% 5.69% -0.35% -0.47% 1.81%
EPS 1 3.52 1.06 22.84 13.36 -11.2 -2.387 2.21 5.679
Change - -69.89% 2,054.72% -41.51% -183.83% 78.69% 192.6% 156.97%
Nbr of stocks (in thousands) 106,457 116,976 117,153 117,353 117,540 117,698 117,698 117,698
Announcement Date 2/17/21 2/16/22 2/15/23 2/14/24 2/12/25 - - -
1USD
Estimates
2025 *2026 *
P/E ratio -79.4x 85.8x
PBR 2.24x 2.25x
EV / Sales 4.85x 4.15x
Yield 0.86% 0.87%
More valuation ratios * Estimated data

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
189.51USD
Average target price
165.06USD
Spread / Average Target
-12.90%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALB Stock
  4. Financials Albemarle Corporation